Numeric Investors’s Regenxbio RGNX Stock Holding History

Numeric Investors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$9.33M	Buy	280,600 +55,571	+25%	+$1.67M	0.07%	279
2017 Q3	$7.42M	Buy	+225,029	New	+$5.06M	0.06%	313

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Numeric Investors's RGNX Position: Q4 2017 in Review

Numeric Investors increased its Regenxbio (RGNX) stake by 25% in Q4 2017, buying an estimated $1.67M and bringing the position to 280,600 shares worth $9.33M. The position accounts for 0.07% of the portfolio, ranked #279.

Numeric Investors first reported a position in RGNX in Q3 2017 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold RGNX as of Q4 2017.

Numeric Investors held 280,600 shares of Regenxbio worth $9.33M as of Q4 2017.
Numeric Investors bought 55,571 Regenxbio shares in Q4 2017, an estimated $1.67M.
Regenxbio made up 0.07% of Numeric Investors's portfolio in Q4 2017, its #279 holding.
Numeric Investors first reported a position in Regenxbio in Q3 2017 and has held it in 2 quarters since.
108 funds tracked by Wall St. Rank held Regenxbio as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.